Medicines Regulations 1984

Schedule 1 Prescription, restricted, and pharmacy-only medicines

r 3

Schedule 1: replaced, on 1 September 2021, by regulation 4 of the Medicines Amendment Regulations (No 2) 2021 (LI 2021/228).

Every reference to a medicine in this schedule applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are—

preparations and admixtures containing any proportion of any substance listed in this schedule:

salts and esters of any substance listed in this schedule:

preparations or extracts of biological materials listed in this schedule:

salts or oxides of elements listed in this schedule.

Unless specific reference is made otherwise, every reference to a medicine in this schedule applies,—

if the medicine is an injection or eye preparation, to any concentration of that medicine; and

if the medicine is not an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol, or element unless specifically stated otherwise.

Part 1 Prescription medicines

Amending or replacing this Part may affect designated prescriber regulations under section 105(1)(q) of the Act.

1

19-norandrostenedione

2

2,4-dinitrochlorobenzene

3

4-aminopyridine

4

4-chloromethandienone

5

4-chlorotestosterone

6

5-aminolevulinic acid

7

Abacavir

8

Abatacept

9

Abciximab

10

Abemaciclib

11

Abiraterone

12

Abrus precatorius; at all strengths

13

Acamprosate

14

Acarbose

15

Acebutolol

16

Acepromazine

17

Acetanilides

18

Acetarsol

19

Acetazolamide

20

Acetohexamide

21

Acetylcarbromal

22

Acetylcholine; except in medicines containing 1 milligram or less per litre or per kilogram

23

Acetylcysteine; for injection or inhalation

24

Acetyldigitoxin

25

Acetylmethyldimethyloximidophenylhydrazine

26

Acetylstrophanthidin

27

Aciclovir; except when specified elsewhere in this schedule

28

Acipimox

29

Acitretin

30

Aclidinium bromide

31

Acokanthera ouabaio

32

Acokanthera schimperi

33

Aconitum spp; except when specified elsewhere in this schedule

34

Acrivastine

35

Adalimumab

36

Adapalene; except in medicines containing 1 milligram or less per millilitre or gram and when supplied by a pharmacist in a pack containing not more than 30 grams for the treatment of comedo, popular, and pustular acne (acne vulgaris) of the face, chest, or back

37

Adefovir

38

Adenosine; for injection

39

Adinazolam

40

Adiphenine

41

Adonis vernalis

42

Adrafinil

43

Adrenal extract; except for dermal use in medicines containing 0.02% or less of ketosteroids

44

Adrenaline; in medicines containing more than 1%

45

Adrenocortical hormones; except adrenal extract for dermal use containing 0.02% or less of ketosteroids

46

Afamelanotide

47

Afatinib

48

Aflibercept

49

Agalsidase

50

Agomelatine

51

Alatrofloxacin

52

Albendazole

53

Albumin; except human albumin

54

Alclofenac

55

Alclometasone; except when specified elsewhere in this schedule

56

Alcohol; for injection in medicines containing more than 20%

57

Alcuronium

58

Aldesleukin

59

Aldosterone; except in medicines containing 10 micrograms or less per litre or per kilogram

60

Alectinib

61

Alefacept

62

Alemtuzumab

63

Alendronic acid

64

Alfacalcidol

65

Alfentanil

66

Alfuzosin

67

Alglucerase

68

Alglucosidase

69

Alirocumab

70

Aliskiren

71

Alitretinoin

72

Alkyl nitrites

73

Alkyl sulfonals

74

Allergens

75

Allopurinol

76

Allylisopropylacetylurea; at all strengths

77

Allyloestrenol

78

Alogliptin

79

Aloracetam

80

Alosetron

81

Alpelisib

82

Alpha1-proteinase inhibitor

83

Alphadolone

84

Alphaxalone

85

Alprazolam

86

Alprenolol

87

Alprostadil

88

Alseroxylon

89

Alteplase

90

Altretamine

91

Amantadine

92

Ambenonium

93

Ambrisentan

94

Ambucetamide

95

Ambutonium

96

Amcinonide

97

Amethocaine; except when specified elsewhere in this schedule; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

98

Amfebutamone

99

Amfepramone

100

Amidopyrine

101

Amifampridine

102

Amifostine

103

Amikacin

104

Amiloride

105

Aminocaproic acid

106

Aminoglutethimide

107

Aminometradine

108

Aminophenazone; at all strengths

109

Aminophylline; except when specified elsewhere in this schedule

110

Aminopterin

111

Aminorex

112

Aminosalicylic acid

113

Amiodarone

114

Amiphenazole

115

Amisometradine

116

Amisulpride

117

Amitriptyline

118

Amlodipine

119

Ammi visnaga

120

Ammonium bromide

121

Amobarbital

122

Amodiaquine

123

Amorolfine; except when specified elsewhere in this schedule; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

124

Amoxapine

125

Amoxycillin

126

Amphomycin

127

Amphotericin

128

Ampicillin

129

Amprenavir

130

Amrinone

131

Amsacrine

132

Amygdalin; at all strengths

133

Amyl nitrite; except when sold to a person who is appropriately authorised under the Health and Safety at Work Act 2015

134

Amylocaine

135

Anabolic steroids

136

Anagrelide

137

Anakinra

138

Anastrozole

139

Ancestim

140

Anchusa officinalis; at all strengths

141

Ancrod and its immunoglobulin antidote

142

Androgenic and anabolic steroidal agents

143

Androgens

144

Androisoxazole

145

Androstanolone

146

Androstenediol

147

Androstenedione

148

Anecortave

149

Angiotensinamide

150

Anidulafungin

151

Aniracetam

152

Anistreplase

153

Antazoline; except for ophthalmic use

154

Antibiotic substances; except when specified elsewhere in this schedule

155

Antigens

156

Antihistamines; except when specified elsewhere in this schedule

157

Antimony; except in medicines containing 1 milligram or less per litre or per kilogram

158

Antisera; for injection

159

AOD-9604

160

Apalutamide

161

Apixaban

162

Apocynum spp

163

Apomorphine; except in medicines containing 1 milligram or less per litre or per kilogram

164

Apraclonidine

165

Apremilast

166

Aprepitant

167

Apronal

168

Aprotinin

169

Arecoline

170

Aripiprazole

171

Aristolochia spp; at all strengths

172

Aristolochic acid; at all strengths

173

Armodafinil

174

Arsenic; except in medicines containing 1 milligram or less per litre or per kilogram

175

Artemether

176

Artemisia annua extract

177

Artesunate

178

Articaine; except when used as a local anaesthetic in practice by a dental therapist or oral health therapist registered with the Dental Council

179

Asenapine

180

Asfotase alfa

181

Asparaginase

182

Aspirin; except when specified elsewhere in this schedule; for injection; when combined with caffeine, paracetamol, or salicylamide

183

Astemizole

184

Asunaprevir

185

Atamestane

186

Atazanavir

187

Atenolol

188

Atezolizumab

189

Atomoxetine

190

Atorvastatin

191

Atosiban

192

Atovaquone

193

Atracurium

194

Atropa belladonna; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

195

Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram

196

Atropine methonitrate

197

Auranofin

198

Aurothiomalate sodium

199

Avanafil

200

Avelumab

201

Avibactam

202

Aviptadil

203

Axitinib

204

Azacitidine

205

Azacyclonol

206

Azapropazone

207

Azaribine

208

Azatadine; except when specified elsewhere in this schedule

209

Azathioprine

210

Azelaic acid; except when specified elsewhere in this schedule

211

Azelastine; except when specified elsewhere in this schedule

212

Azithromycin

213

Azlocillin

214

Aztreonam

215

Bacampicillin

216

Bacitracin

217

Baclofen

218

Baloxavir marboxil

219

Balsalazide

220

Bambuterol

221

Bamethan

222

Bamipine

223

Bamlanivimab

224

Barbital

225

Barbiturates

226

Baricitinib

227

Basiliximab

228

Bazedoxifene

229

Becaplermin

230

Beclamide

231

Beclomethasone; except when specified elsewhere in this schedule

232

Bedaquiline

233

Belatacept

234

Belimumab

235

Bemegride

236

Benactyzine

237

Benazepril

238

Bendamustine

239

Bendrofluazide

240

Benethamine penicillin

241

Benorylate

242

Benoxaprofen

243

Benperidol

244

Benralizumab

245

Benserazide

246

Benzathine penicillin

247

Benzatropine

248

Benzbromarone

249

Benzhexol

250

Benzilonium

251

Benzocaine; except when specified elsewhere in this schedule

252

Benzodiazepine derivatives; except when specified elsewhere in this schedule

253

Benzodiazepines; except when specified elsewhere in this schedule

254

Benzoyl metronidazole

255

Benzoyl peroxide; except when specified elsewhere in this schedule

256

Benzthiazide

257

Benzydamine; except when specified elsewhere in this schedule

258

Benzylpenicillin

259

Bepridil

260

Beractant

261

Besifloxacin

262

Beta carotene; in medicines containing more than 18 milligrams per recommended daily dose

263

Betahistine

264

Betaine; for the treatment of homocystinuria

265

Betamethasone

266

Betaxolol

267

Bethanechol

268

Bethanidine

269

Bevacizumab

270

Bevantolol

271

Bexarotene

272

Bezafibrate

273

Bezlotoxumab

274

Bicalutamide

275

Bictegravir

276

Bifonazole; except when specified elsewhere in this schedule

277

Bilastine; except when specified elsewhere in this schedule

278

Bimatoprost

279

Binimetinib

280

Biperiden

281

Bismuth; except for external use in medicines containing 3% or less

282

Bisoprolol

283

Bithionol; at all strengths

284

Bivalirudin

285

Bleomycin

286

Blinatumomab

287

Boceprevir

288

Bolandiol

289

Bolasterone

290

Bolazine

291

Boldenone

292

Bolenol

293

Bolmantalate

294

Boron, including borax and boric acid; except in medicines for internal use containing 6 milligrams or less per recommended daily dose; except in medicines for dermal use other than paediatric use containing 0.35% or less; except when present as an excipient

295

Bortezomib

296

Bosentan

297

Bosutinib

298

Botulinum toxins

299

Brentuximab vedotin

300

Bretylium

301

Brexpiprazole

302

Brigatinib

303

Brimonidine

304

Brinzolamide

305

Brivaracetam (and its stereoisomers)

306

Brolucizumab

307

Bromazepam

308

Bromocriptine

309

Bromoform

310

Brompheniramine; except when specified elsewhere in this schedule

311

Bromvaletone

312

Brotizolam

313

Brugmansia spp

314

Buclizine; except for oral use

315

Budesonide; except when specified elsewhere in this schedule

316

Bufexamac; except in suppositories; except for dermal use in medicines containing 5% or less

317

Bumetanide

318

Buniodyl sodium; at all strengths

319

Buphenine

320

Bupivacaine

321

Buprenorphine

322

Bupropion

323

Buserelin

324

Buspirone

325

Busulphan

326

Butacaine

327

Butobarbital

328

Butoconazole; except for vaginal use

329

Butorphanol

330

Butyl aminobenzoate; except in medicines for dermal use containing 2% or less

331

Butyl nitrite

332

Butylchloral hydrate

333

Cabazitaxel

334

Cabergoline

335

Cabotegravir

336

Cabozantinib

337

Cacalia spp; at all strengths

338

Cadmium

339

Calcipotriol; except in medicines containing not more than 50 micrograms per gram or per millilitre and when sold in a pack of not more than 30 grams or 30 millilitres by a pharmacist to an adult with mild to moderate psoriasis previously diagnosed by a doctor

340

Calcitonin

341

Calcitriol

342

Calcium carbimide

343

Calcium polystyrene sulphonate

344

Calotropis gigantea

345

Calotropis procera

346

Calusterone

347

Camazepam

348

Camphorated oil

349

Camphotamide

350

Canagliflozin

351

Canakinumab

352

Candesartan

353

Candicidin

354

Cannabidiol

355

Capecitabine

356

Capreomycin

357

Captodiame

358

Captopril

359

Capuride

360

Caramiphen

361

Carbachol

362

Carbamazepine

363

Carbaryl; except for external use in medicines containing 2% or less

364

Carbazochrome

365

Carbenicillin

366

Carbenoxolone; except for external use

367

Carbetocin

368

Carbidopa

369

Carbimazole

370

Carbocromen

371

Carboplatin

372

Carboprost

373

Carbromal

374

Carbutamide

375

Carbuterol

376

Carfilzomib

377

Carglumic acid

378

Carindacillin

379

Carisoprodol

380

Carmustine

381

Carprofen

382

Carvedilol

383

Caspofungin

384

Catumaxomab

385

Cebaracetam (and its stereoisomers)

386

Cedazuridine

387

Cefacetrile

388

Cefaclor

389

Cefaloridine

390

Cefamandole

391

Cefapirin

392

Cefazolin

393

Cefepime

394

Cefetamet

395

Cefixime

396

Cefodizime

397

Cefonicid

398

Cefoperazone

399

Cefotaxime

400

Cefotetan

401

Cefotiam

402

Cefoxitin

403

Cefpirome

404

Cefpodoxime

405

Cefsulodin

406

Ceftaroline fosamil

407

Ceftazidime

408

Ceftibuten

409

Ceftolozane

410

Ceftriaxone

411

Cefuroxime

412

Celecoxib

413

Celiprolol

414

Cenegermin

415

Cephaelis acuminata; except in medicines containing less than 0.2% of emetine

416

Cephaelis ipecacuanha; except in medicines containing less than 0.2% of emetine

417

Cephalexin

418

Cephalothin

419

Cephradine

420

Ceritinib

421

Cerivastatin

422

Cerliponase alfa

423

Certolizumab pegol

424

Ceruletide

425

Cetirizine; except when specified elsewhere in this schedule

426

Cetrorelix

427

Cetuximab

428

Chenodeoxycholic acid

429

Chloral hydrate; except for dermal use in medicines containing 2% or less

430

Chloralformamide

431

Chloralose

432

Chlorambucil

433

Chloramphenicol; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except when specified elsewhere in this schedule

434

Chlorandrostenolone

435

Chlorazanil

436

Chlorcyclizine

437

Chlordiazepoxide

438

Chlormerodrin

439

Chlormethiazole

440

Chlormezanone

441

Chloroform; for anaesthesia; except when specified elsewhere in this schedule

442

Chloroquine

443

Chlorothiazide

444

Chlorotrianisene

445

Chloroxydienone

446

Chloroxymesterone

447

Chlorpheniramine; except when specified elsewhere in this schedule

448

Chlorphentermine

449

Chlorpromazine

450

Chlorpropamide

451

Chlorprothixene

452

Chlorquinaldol

453

Chlortetracycline

454

Chlorthalidone

455

Chlorzoxazone

456

Cholera vaccine; except in the form of an oral liquid containing vibrio cholerae when sold in a pharmacy by a registered pharmacist

457

Cholic acid

458

Choline salicylate; except in medicines containing 10% or less and in pack sizes of 15 grams or less

459

Chorionic gonadotrophin; except in pregnancy test kits

460

Chymopapain

461

Ciclacillin

462

Ciclesonide

463

Ciclopirox; except when specified elsewhere in this schedule

464

Cidofovir

465

Cilastatin

466

Cilazapril

467

Cilnidipine

468

Cilostazol

469

Cimetidine; except when specified elsewhere in this schedule

470

Cinacalcet

471

Cinchocaine; for injection; for ophthalmic use; for external use in medicines containing more than 0.5%

472

Cinchophen

473

Cinnarizine

474

Cinoxacin

475

Ciprofloxacin

476

Cisapride

477

Cisatracurium

478

Cisplatin

479

Citalopram

480

CJC-1295

481

Cladribine

482

Clarithromycin

483

Clavulanic acid

484

Clemastine; except for oral use

485

Clemizole

486

Clenbuterol

487

Clevidipine

488

Clidinium

489

Clindamycin

490

Clioquinol; at all strengths

491

Clobazam

492

Clobetasol

493

Clobetasone; except when specified elsewhere in this schedule

494

Clocortolone

495

Clodronic acid

496

Clofarabine

497

Clofazimine

498

Clofenamide

499

Clofibrate

500

Clomiphene

501

Clomipramine

502

Clomocycline

503

Clonazepam

504

Clonidine

505

Clopamide

506

Clopidogrel

507

Clorazepic acid

508

Clorexolone

509

Clorprenaline

510

Clostebol

511

Clotiazepam

512

Clotrimazole; except when specified elsewhere in this schedule

513

Cloxacillin

514

Cloxazolam

515

Clozapine

516

Cobalt

517

Cobicistat

518

Cobimetinib

519

Cocaine; except when specified elsewhere in this schedule

520

Codeine

521

Co-dergocrine

522

Colaspase

523

Colchicine

524

Colchicum

525

Colecalciferol; except in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

526

Colestipol

527

Colestyramine

528

Colfosceril

529

Colistin

530

Collagen; in injections or implants for tissue augmentation or cosmetic use

531

Collagenase clostridium histolyticum

532

Coluracetam

533

Conium maculatum; at all strengths

534

Convallaria keiski

535

Convallaria majalis

536

Corifollitropin alfa

537

Coronilla spp

538

Corticosterone

539

Corticotrophin

540

Cortisone and other steroidal hormones of the adrenal cortex; except when specified elsewhere in this schedule; except adrenal extract for dermal use in medicines containing 0.02% or less of ketosteroids

541

Cotarnine; at all strengths

542

Co-trimoxazole

543

Coumarin

544

COVID-19 vaccines; except when administered by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the COVID-19 Vaccinator Education Course (or any equivalent training course on COVID-19 vaccination approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course or the COVID-19 Vaccinator - Working under Supervision Course)

545

Crisaborole

546

Crizotinib

547

Crofelemer

548

Crotalaria spp; at all strengths

549

Croton tiglium; except in medicines containing 1 milligram or less per litre or per kilogram

550

Crystal violet

551

Curare

552

Cyclandelate

553

Cyclizine; except when specified elsewhere in this schedule

554

Cyclobenzaprine

555

Cyclofenil

556

Cycloheximide

557

Cyclopenthiazide

558

Cyclopentolate; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

559

Cyclophosphamide

560

Cyclopropane

561

Cycloserine

562

Cyclosporin

563

Cyclothiazide

564

Cycrimine

565

Cymarin

566

Cynoglossum spp; at all strengths

567

Cyproheptadine; except for oral use

568

Cyproterone

569

Cysteamine

570

Cytarabine

571

Dabigatran

572

Dabrafenib mesilate

573

Dacarbazine

574

Daclatasvir

575

Daclizumab

576

Dactinomycin

577

Dalfopristin

578

Dalteparin

579

Danaparoid

580

Danazol

581

Danthron

582

Dantrolene

583

Dapagliflozin

584

Dapoxetine

585

Dapsone

586

Daptomycin

587

Daratumumab

588

Darbepoetin

589

Darifenacin

590

Darolutamide

591

Darunavir

592

Dasabuvir

593

Dasatinib

594

Datura spp; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

595

Daunorubicin

596

Deanol

597

Debrisoquine

598

Decamethonium

599

Decitabine

600

Deferasirox

601

Deferiprone

602

Defibrotide

603

Deflazacort

604

Degarelix

605

Dehydrochloromethyltestosterone

606

Dehydrocorticosterone

607

Delavirdine

608

Delorazepam

609

Demecarium

610

Demeclocycline

611

Denosumab

612

Deoxycortone

613

Deoxycholic acid; for injection; except for oral use

614

Deoxyribonuclease; except for external use

615

Dermatophagoides farina allergen extract

616

Dermatophagoides pteronyssinus allergen extract

617

Desferrioxamine

618

Desflurane

619

Desipramine

620

Desirudin

621

Deslanoside

622

Desloratadine; except for oral use

623

Deslorelin

624

Desmopressin

625

Desogestrel; except when supplied for oral contraception to women who meet the clinical and eligbility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

626

Desonide

627

Desoximetasone

628

Desvenlafaxine

629

Dexamethasone

630

Dexamfetamine

631

Dexchlorpheniramine; except when specified elsewhere in this schedule

632

Dexfenfluramine

633

Dexmedetomidine

634

Dextromethorphan; except when specified elsewhere in this schedule

635

Dextromoramide

636

Dextropropoxyphene

637

Dextrorphan

638

Di-iodohydroxy quinoline; except when specified elsewhere in this schedule

639

Di-isopropylamine dichloroacetate

640

Diazepam

641

Diazoxide

642

Dibenzepin

643

Dibotermin

644

Dibrompropamidine; except for ophthalmic use

645

Dichloralphenazone

646

Dichlorophen

647

Dichlorphenamide

648

Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this schedule; except in preparations for topical use other than for the treatment of solar keratosis

649

Dicloxacillin

650

Dicyclomine

651

Didanosine

652

Dienoestrol

653

Dienogest

654

Diethazine

655

Diethylcarbamazine

656

Diethylstilbestrol

657

Diflorasone

658

Diflucortolone

659

Diflunisal

660

Digitalis lanata

661

Digitalis purpurea

662

Digitoxin

663

Digoxin

664

Digoxin-specific antibody fragment

665

Dihydralazine

666

Dihydrocodeine

667

Dihydroergotoxine

668

Dihydrolone

669

Dihydrotachysterol

670

Diltiazem

671

Dimenhydrinate; except when specified elsewhere in this schedule

672

Dimercaprol

673

Dimethandrostanolone

674

Dimethazine

675

Dimethindene; except for oral use

676

Dimethothiazine

677

Dimethoxanate

678

Dimethyl fumarate

679

Dimethyl sulphoxide

680

Dimiracetam (and its stereoisomers)

681

Dinitrocresols

682

Dinitronaphthols

683

Dinitrophenols

684

Dinitrothymols

685

Dinoprost

686

Dinoprostone

687

Diperodon

688

Diphemanil; except for dermal use

689

Diphenhydramine; except when specified elsewhere in this schedule

690

Diphenidol

691

Diphenoxylate; except when specified elsewhere in this schedule

692

Diphenylpyraline

693

Diphtheria, tetanus, and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over or to a pregnant woman aged 13 years or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)

694

Diphtheria toxoid

695

Diphtheria vaccine

696

Dipivefrin

697

Dipyridamole

698

Dirithromycin

699

Disopyramide

700

Distigmine

701

Disulfiram

702

Disulphamide

703

Ditiocarb

704

DMHA, including the isomers 2-amino-6-methylheptane (also known as 1,5-dimethylhexylamine, and octodrine) and 2-amino-5-methylheptane (also known as 1,4-dimethylhexylamine)

705

Dobutamine

706

Docetaxel

707

Dofetilide

708

Dolasetron

709

Doliracetam (and its stereoisomers)

710

Dolutegravir

711

Domperidone

712

Donepezil

713

Dopamine

714

Dopexamine

715

Doravirine

716

Doripenem

717

Dornase

718

Dorzolamide

719

Dothiepin

720

Doxantrazole

721

Doxapram

722

Doxazosin

723

Doxepin

724

Doxorubicin

725

Doxycycline

726

Doxylamine; except when specified elsewhere in this schedule

727

Dronedarone

728

Droperidol

729

Drospirenone

730

Drostanolone

731

Drotrecogin

732

Duboisia leichhardtii; except when specified elsewhere in this schedule

733

Duboisia myoporides; except when specified elsewhere in this schedule

734

Dulaglutide

735

Dulcin; at all strengths

736

Duloxetine

737

Dupilumab

738

Dupracetam

739

Durvalumab

740

Dutasteride

741

Dydrogesterone

742

Econazole; except when specified elsewhere in this schedule

743

Ecothiopate

744

Ectylurea

745

Eculizumab

746

Edetic acid; except in medicines containing 0.25% or less; except in contact lens preparations; except dicobalt edetate for the treatment of cyanide poisoning

747

Edoxudine

748

Edrophonium

749

Efalizumab

750

Efavirenz

751

Eflornithine

752

Elbasvir

753

Eletriptan

754

Elosulfase alfa

755

Elotuzumab

756

Eltrombopag olamine

757

Eluxadoline

758

Elvitegravir

759

Emepronium

760

Emetine; except in medicines containing 0.2% or less

761

Emicizumab

762

Empagliflozin

763

Emtricitabine

764

Enalapril

765

Enasidenib

766

Encorafenib

767

Enestebol

768

Enflurane

769

Enfuvirtide

770

Enobosarm

771

Enoxacin

772

Enoxaparin

773

Enoximone

774

Enprostil

775

Entacapone

776

Entecavir

777

Entrectinib

778

Enzalutamide

779

Ephedrine

780

Epicillin

781

Epinastine

782

Epirubicin

783

Epitiostanol

784

Eplerenone

785

Epoetins

786

Epoprostenol

787

Eprosartan

788

Eptifibatide

789

Erenumab

790

Ergocalciferol; except in medicines containing 25 micrograms or less per recommended daily dose

791

Ergometrine

792

Ergot

793

Ergotamine

794

Ergotoxine

795

Eribulin

796

Erlotinib

797

Ertapenem

798

Ertugliflozin

799

Erysimum spp; except in medicines containing 1 milligram or less per litre or per kilogram

800

Erythromycin

801

Erythropoietin

802

Escitalopram

803

Esketamine

804

Esmolol

805

Esomeprazole; except when specified elsewhere in this schedule

806

Estazolam

807

Estramustine

808

Estropipate

809

Etanercept

810

Ethacrynic acid

811

Ethambutol

812

Ethamivan

813

Ethanolamine; for injection

814

Ethchlorvynol

815

Ether; for anaesthesia; except when specified elsewhere in this schedule

816

Ethinamate

817

Ethinyloestradiol; except when supplied at a strength of 35 micrograms or less in combination with either levonorgestrel or norethisterone for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

818

Ethionamide

819

Ethisterone

820

Ethoglucid

821

Ethoheptazine

822

Ethopropazine

823

Ethosuximide

824

Ethotoin

825

Ethoxzolamide

826

Ethyl chloride; for inhalation

827

Ethyl loflazepate

828

Ethyldienolone

829

Ethylhexanediol; at all strengths

830

Ethyloestrenol

831

Ethynodiol

832

Etidocaine

833

Etidronic acid; except in medicines for external use containing 1% or less

834

Etilefrine

835

Etiracetam

836

Etodolac

837

Etofenamate; except for external use

838

Etomidate

839

Etonogestrel

840

Etoposide

841

Etoricoxib

842

Etravirine

843

Etretinate

844

Everolimus

845

Evolocumab

846

Exemestane

847

Exenatide

848

Ezetimibe

849

Factor VIII inhibitor bypassing fraction

850

Famciclovir; except when specified elsewhere in this schedule

851

Famotidine; except when specified elsewhere in this schedule

852

Fampridine

853

Farfugium japonicum; at all strengths

854

Fasoracetam (and its stereoisomers)

855

Febuxostat

856

Felbamate

857

Felbinac; except for external use

858

Felodipine

859

Felypressin; except when combined with a local anaesthetic and used in practice by a dental therapist or oral health therapist registered with the Dental Council

860

Fenbufen

861

Fenclofenac

862

Fenfluramine

863

Fenofibrate

864

Fenoldopam

865

Fenoprofen

866

Fenoterol

867

Fenpipramide

868

Fenpiprane

869

Fentanyl

870

Ferric carboxymaltose

871

Ferric derisomaltose

872

Fexofenadine; except when specified elsewhere in this schedule

873

Fibrin

874

Fibrinolysin; except for external use

875

Fibroblast growth factor

876

Fidaxomicin

877

Filgrastim

878

Finasteride

879

Fingolimod

880

Flecainide

881

Fleroxacin

882

Floctafenine

883

Fluanisone

884

Flubromazolam

885

Fluclorolone

886

Flucloxacillin

887

Fluconazole; except when specified elsewhere in this schedule

888

Flucytosine

889

Fludarabine

890

Fludiazepam

891

Fludrocortisone

892

Flufenamic acid

893

Flumazenil

894

Flumethasone

895

Flumethiazide

896

Flunarizine

897

Flunisolide

898

Flunitrazepam

899

Fluocinolone

900

Fluocinonide

901

Fluocortin

902

Fluocortolone

903

Fluorescein; for injection

904

Fluorides; for internal use in medicines containing more than 0.5 milligrams per dose unit except in medicines containing 15 milligrams or less per litre or per kilogram; except in parenteral nutrition replacement preparations; for external use in medicines containing more than 5.5 grams per litre or per kilogram except when supplied to a dental professional registered with the Dental Council

905

Fluorometholone

906

Fluorouracil

907

Fluoxetine

908

Fluoxymesterone

909

Flupenthixol

910

Fluphenazine

911

Flurandrenolone

912

Flurazepam

913

Flurbiprofen; except when specified elsewhere in this schedule

914

Fluroxene

915

Fluspirilene

916

Flutamide

917

Fluticasone; except when specified elsewhere in this schedule

918

Fluvastatin

919

Fluvoxamine

920

Folic acid; except when specified elsewhere in this schedule

921

Folinic acid; except when specified elsewhere in this schedule

922

Follicle-stimulating hormone; except in medicines containing 100 micrograms or less per litre or per kilogram

923

Follistatin

924

Follitropin

925

Follitropin delta

926

Fomepizole

927

Fomivirsen

928

Fondaparinux

929

Fonturacetam (and its stereoisomers)

930

Formebolone

931

Formestane

932

Formoterol

933

Fosamprenavir

934

Fosaprepitant

935

Foscarnet

936

Fosfestrol

937

Fosfomycin

938

Fosinopril

939

Fosnetupitant

940

Fosphenytoin

941

Fotemustine

942

Framycetin

943

Fremanezumab

944

Fulvestrant

945

Furaltadone

946

Furazabol

947

Furazolidone

948

Furosemide

949

Fusidic acid

950

Gabapentin

951

Galantamine

952

Galanthus spp

953

Galcanezumab

954

Gallamine

955

Galsulfase

956

Ganciclovir

957

Ganirelix

958

Gatifloxacin

959

Gefitinib

960

Gemcitabine

961

Gemeprost

962

Gemfibrozil

963

Gemifloxacin

964

Gemtuzumab ozogamicin

965

Gentamicin

966

Gestodene

967

Gestonorone

968

Gestrinone

969

Ghrelin

970

Gilteritinib

971

Gitalin

972

Glatiramer acetate

973

Glecaprevir

974

Glibenclamide

975

Glibornuride

976

Gliclazide

977

Glimepiride

978

Glipizide

979

Glisoxepide

980

Glutathione; for injection

981

Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram

982

Glycopyrronium

983

Glymidine

984

Golimumab

985

Gonadorelin

986

Gonadotrophic hormones; except when specified elsewhere in this schedule

987

Goserelin

988

Gramicidin

989

Granisetron

990

Grazoprevir

991

Grepafloxacin

992

Griseofulvin

993

Growth hormone releasing hormones

994

Growth hormone releasing peptide-6

995

Growth hormone releasing peptides

996

Guaifenesin; except when specified elsewhere in this schedule

997

Guanabenz

998

Guanethidine

999

Guanfacine

1000

Guanidine

1001

Guselkumab

1002

Hachimycin

1003

Haematin

1004

Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1005

Halazepam

1006

Halcinonide

1007

Halofantrine

1008

Halofenate

1009

Haloperidol; except in medicines containing 1 milligram or less per litre or per kilogram

1010

Halothane

1011

Haloxazolam

1012

Halquinol; except for external use

1013

Heliotropium spp; at all strengths

1014

Hemerocallis

1015

Heparins; except when present as an excipient; except for external use

1016

Hepatitis A vaccine

1017

Hepatitis B vaccine

1018

Hetacillin

1019

Hexachlorophane; in medicines containing more than 3%; except when specified elsewhere in this schedule

1020

Hexamethonium

1021

Hexarelin

1022

Hexetidine; except for external use

1023

Hexobendine

1024

Hexocyclium

1025

Hexoprenaline

1026

Hexaminolevulinate

1027

Histamine; except in medicines containing 0.5% or less

1028

Homatropine

1029

Human chorionic gonadotrophin; except in pregnancy test kits

1030

Human growth hormone secretagogues

1031

Human papillomavirus vaccine; except when administered by a registered pharmacist or registered intern pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)

1032

Human protein C

1033

Hyaluronic acid; in injections or implants for tissue augmentation or cosmetic use

1034

Hydralazine

1035

Hydrargaphen

1036

Hydrochlorothiazide

1037

Hydrocortisone; except when specified elsewhere in this schedule

1038

Hydrocyanic acid; except when specified elsewhere in this schedule

1039

Hydroflumethiazide

1040

Hydromorphone

1041

Hydroquinone; except when specified elsewhere in this schedule

1042

Hydroxychloroquine

1043

Hydroxyephedrine

1044

Hydroxyphenamate

1045

Hydroxyprogesterone

1046

Hydroxystenozol

1047

Hydroxyurea

1048

Hydroxyzine

1049

Hylan polymer; in injections or implants for tissue augmentation or cosmetic use

1050

Hyoscine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

1051

Hyoscine butylbromide; except when specified elsewhere in this schedule

1052

Hyoscyamine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

1053

Hyoscyamus niger; except when specified elsewhere in this schedule

1054

Hypothalamic releasing factors

1055

Hypromellose; for injection; except in intraocular viscoelastic products

1056

Ibandronic acid

1057

Ibogaine

1058

Ibritumomab tiuxetan

1059

Ibrutinib

1060

Ibufenac

1061

Ibuprofen; except when specified elsewhere in this schedule

1062

Ibutamoren

1063

Ibuterol

1064

Ibutilide

1065

Icatibant

1066

Idarubicin

1067

Idarucizumab

1068

Idebenone

1069

Idelalisib

1070

Idoxuridine; except for dermal use in medicines containing 0.5% or less

1071

Idursulfase

1072

Ifosfamide

1073

Iloprost

1074

Imatinib

1075

Imiglucerase

1076

Imipenem

1077

Imipramine

1078

Imiquimod

1079

Immunoglobulins

1080

Imuracetam

1081

Indacaterol

1082

Indapamide

1083

Indinavir

1084

Indocyanine green

1085

Indomethacin; except when specified elsewhere in this schedule

1086

Indoprofen

1087

Indoramin

1088

Infliximab

1089

Influenza and coryza vaccines; for injection; for nasal use

1090

Influenza vaccine; except when administered to a person 13 years of age or over by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)

1091

Ingenol mebutate

1092

Inotuzumab ozogamicin

1093

Insulin degludec

1094

Insulin-like growth factors; except when specified elsewhere in this schedule

1095

Insulins

1096

Interferons

1097

Interleukins

1098

Iodothiouracil

1099

Ipamorelin

1100

Ipecacuanha; except when specified elsewhere in this schedule

1101

Ipilimumab

1102

Ipratropium; except for nasal use

1103

Ipriflavone

1104

Iprindole

1105

Iproniazid

1106

Irbesartan

1107

Irinotecan

1108

Iron; except when specified elsewhere in this schedule

1109

Isatuximab

1110

Isavuconazole

1111

Isoaminile

1112

Isoamyl nitrite

1113

Isobutyl nitrite

1114

Isocarboxazid

1115

Isoconazole; except when specified elsewhere in this schedule

1116

Isoetarine

1117

Isoflurane

1118

Isometheptene

1119

Isoniazid

1120

Isoprenaline

1121

Isoprinosine

1122

Isopropamide; except when specified elsewhere in this schedule

1123

Isosorbide dinitrate

1124

Isosorbide mononitrate

1125

Isotretinoin

1126

Isoxicam

1127

Isoxsuprine

1128

Isradipine

1129

Itraconazole

1130

Ivabradine

1131

Ivacaftor

1132

Ivermectin

1133

Ixabepilone

1134

Ixazomib

1135

Ixekizumab

1136

Japanese encephalitis vaccine

1137

Juniperus sabina; at all strengths

1138

Kanamycin

1139

Ketamine

1140

Ketanserin

1141

Ketazolam

1142

Ketoconazole; except when specified elsewhere in this schedule

1143

Ketoprofen; except when specified elsewhere in this schedule

1144

Ketorolac

1145

Ketotifen; except for ophthalmic use in medicines containing 0.025% or less

1146

Khellin

1147

Labetalol

1148

Lacidipine

1149

Lacosamide

1150

Lamivudine

1151

Lamotrigine

1152

Lanadelumab

1153

Lanatosides

1154

Lanreotide

1155

Lansoprazole; except when specified elsewhere in this schedule

1156

Lanthanum

1157

Lapatinib

1158

Laronidase-rch

1159

Laropiprant

1160

Larotrectinib

1161

Latamoxef

1162

Latanoprost

1163

Laudexium

1164

Lauromacrogols; for injection

1165

Lead

1166

Ledipasvir

1167

Lefetamine

1168

Leflunomide

1169

Lenalidomide

1170

Lenograstim

1171

Lenvatinib

1172

Lepirudin

1173

Leptazol

1174

Lercanidipine

1175

Lesinurad

1176

Letermovir

1177

Letrozole

1178

Leucovorin; for injection

1179

Leuprorelin

1180

Levallorphan

1181

Levamisole

1182

Levetiracetam

1183

Levobunolol

1184

Levobupivacaine

1185

Levocabastine; except for nasal or ophthalmic use

1186

Levocetirizine; except for oral use

1187

Levodopa

1188

Levomepromazine

1189

Levomilnacipran

1190

Levonorgestrel; except when specified elsewhere in this schedule; except in medicines for use as emergency post-coital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

1191

Levosimendan

1192

Lidoflazine

1193

Lidocaine; for injection except when used as a local anaesthetic in practice by a nurse whose scope of practice permits the performance of general nursing functions or by a podiatrist registered with the Podiatrists Board or by a dental therapist or an oral health therapist registered with the Dental Council; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for external use in medicines containing more than 10%; except in throat sprays in medicines containing 2% or less; except when specified elsewhere in this schedule

1194

Lifitegrast

1195

Ligularia dentata; at all strengths

1196

Linaclotide

1197

Linagliptin

1198

Lincomycin

1199

Lindane; except for external use in medicines containing 2% or less

1200

Linezolid

1201

Liothyronine

1202

Lipegfilgrastim

1203

Liraglutide

1204

Lisdexamfetamine

1205

Lisinopril

1206

Lisuride

1207

Lithium; except when specified elsewhere in this schedule; except when present as an excipient in dermal medicines containing 0.25% or less

1208

Lixisenatide

1209

Lodoxamide; except in medicines for ophthalmic use

1210

Lofexidine

1211

Lomefloxacin

1212

Lomustine

1213

Loperamide; except when specified elsewhere in this schedule

1214

Lopinavir

1215

Loprazolam

1216

Loracarbef

1217

Loratadine; except when specified elsewhere in this schedule

1218

Lorazepam

1219

Lorlatinib

1220

Lormetazepam

1221

Losartan

1222

Loteprednol

1223

Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches

1224

Loxapine

1225

Lumacaftor

1226

Lumefantrine

1227

Lumiracoxib

1228

Lurasidone

1229

Luteinising hormone

1230

Lymecycline

1231

Macitentan

1232

Mafenide

1233

Mannomustine

1234

Maprotiline

1235

Maraviroc

1236

Mazindol

1237

Measles vaccine; except when administered, in combination with mumps and rubella vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)

1238

Mebanazine

1239

Mebeverine

1240

Mebhydrolin

1241

Mebolazine

1242

Mebutamate

1243

Mecamylamine

1244

Mecasermin

1245

Mecillinam

1246

Meclocycline

1247

Meclofenamate

1248

Meclofenoxate

1249

Meclozine; except when specified elsewhere in this schedule

1250

Medazepam

1251

Medigoxin

1252

Medroxyprogesterone

1253

Medrysone

1254

Mefenamic acid; except when specified elsewhere in this schedule

1255

Mefloquine

1256

Mefruside

1257

Megestrol

1258

Melagatran

1259

Melanocyte stimulating compounds

1260

Melatonin; except when supplied in medicines for oral use containing 3 milligrams or less per immediate release dose unit, or 2 milligrams or less per modified release dose unit, when sold in the manufacturer’s original pack that has received consent from the Minister of Health or the Director General for the treatment of primary insomnia for adults aged 55 years or older for up to 13 weeks by a registered pharmacist

1261

Meldonium

1262

Melengestrol

1263

Melia azedarach; at all strengths

1264

Meloxicam

1265

Melphalan

1266

Memantine

1267

Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)

1268

Menotrophin

1269

Mepacrine

1270

Mepenzolate

1271

Mephenesin

1272

Mephentermine

1273

Mepindolol

1274

Mepitiostane

1275

Mepivacaine

1276

Mepolizumab

1277

Meprobamate

1278

Meptazinol

1279

Mepyramine; except when specified elsewhere in this schedule

1280

Mequitazine

1281

Mercaptomerin

1282

Mercaptopurine

1283

Mercurochrome; except when specified elsewhere in this schedule

1284

Mercury; except when specified elsewhere in this schedule

1285

Meropenem

1286

Mersalyl

1287

Mesabolone

1288

Mesalazine

1289

Mesna

1290

Mestanolone

1291

Mesterolone

1292

Mestranol

1293

Metamfetamine

1294

Metamizole

1295

Metandienone

1296

Metaraminol

1297

Metenolone

1298

Metergoline

1299

Metformin

1300

Methacholine

1301

Methacycline

1302

Methadone

1303

Methallenoestril

1304

Methandriol

1305

Methanthelinium

1306

Methazolamide

1307

Methdilazine; except for oral use

1308

Methicillin

1309

Methimazole

1310

Methisazone

1311

Methixene

1312

Methocarbamol

1313

Methohexitone

1314

Methoin

1315

Methotrexate

1316

Methoxamine; except when specified elsewhere in this schedule

1317

Methoxsalen

1318

Methoxyflurane

1319

Methsuximide

1320

Methyclothiazide

1321

Methyl aminolevulinate

1322

Methyl androstanolone

1323

Methyl clostebol

1324

Methyl mercury; except in medicines containing 300 micrograms or less per litre or per kilogram

1325

Methyl salicylate; except for external use; except for internal use when present as an excipient in medicines containing 1.04% or less per dose form

1326

Methyl trienolone

1327

Methyldopa

1328

Methylene blue; for injection

1329

Methylergometrine

1330

Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring substance

1331

Methylnaltrexone

1332

Methylpentynol

1333

Methylphenidate

1334

Methylphenobarbital

1335

Methylphenylpiracetam

1336

Methylprednisolone

1337

Methyltestosterone

1338

Methylthiouracil

1339

Methyprylon

1340

Methysergide

1341

Metoclopramide; except when specified elsewhere in this schedule

1342

Metolazone

1343

Metoprolol

1344

Metribolone

1345

Metrifonate

1346

Metronidazole

1347

Metyrapone

1348

Mexiletine

1349

Mezlocillin

1350

Mianserin

1351

Mibefradil

1352

Mibolerone

1353

Micafungin

1354

Miconazole; except when specified elsewhere in this schedule

1355

Midazolam

1356

Midodrine

1357

Midostaurin

1358

Mifepristone

1359

Migalastat

1360

Miglitol

1361

Miglustat

1362

Milnacipran

1363

Milrinone

1364

Minocycline

1365

Minoxidil; except for dermal use in medicines containing 5% or less

1366

Mirabegron

1367

Mirtazapine

1368

Misoprostol

1369

Mitobronitol

1370

Mitomycin

1371

Mitoxantrone

1372

Mitragyna speciosa

1373

Mitragynine

1374

Mivacurium

1375

Moclobemide

1376

Modafinil

1377

Molgramostim

1378

Molindone

1379

Molracetam

1380

Mometasone; except when specified elsewhere in this schedule

1381

Monobenzone

1382

Monoclonal antibodies; except in pregnancy test kits

1383

Montelukast

1384

Moperone

1385

Morazone

1386

Moricizine

1387

Morphine; except when specified elsewhere in this schedule

1388

Motrazepam

1389

Motretinide

1390

Moxifloxacin

1391

Mumps vaccine; except when administered, in combination with measles and rubella vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)

1392

Mupirocin

1393

Muraglitazar

1394

Muromonab

1395

Mustine

1396

Mycophenolic acid

1397

Nabilone

1398

Nabumetone

1399

Nadolol

1400

Nadroparin

1401

Nafarelin

1402

Naftidrofuryl

1403

Nalbuphine

1404

Nalidixic acid

1405

Nalmefene

1406

Nalorphine

1407

Naloxegol

1408

Naloxone; except when provided as part of an approved emergency kit for the treatment of opioid overdose

1409

Naltrexone

1410

Nandrolone

1411

Naproxen; except when specified elsewhere in this schedule

1412

Naratriptan

1413

Natalizumab

1414

Natamycin

1415

Nateglinide

1416

Nebacumab

1417

Nebivolol

1418

Nebracetam (and its stereoisomers)

1419

Nedocromil

1420

Nefazodone

1421

Nefiracetam

1422

Nefopam

1423

Nelfinavir

1424

Neomycin

1425

Neostigmine

1426

Nepafenac

1427

Nepidermin

1428

Neratinib

1429

Nerium oleander

1430

Nesiritide

1431

Netilmicin

1432

Netupitant

1433

Nevirapine

1434

Nialamide

1435

Nicardipine

1436

Nicergoline

1437

Nicofuranose

1438

Nicoracetam

1439

Nicorandil

1440

Nicotine; except when specified elsewhere in this schedule; except in preparations for oromucosal or transdermal absorption; for nasal use except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner; in medicines other than for smoking cessation

1441

Nicotinic acid except nicotinamide; except when specified elsewhere in this schedule

1442

Nicoumalone

1443

Nifedipine

1444

Nifenazone

1445

Nikethamide

1446

Nilotinib

1447

Nilutamide

1448

Nimesulide

1449

Nimetazepam

1450

Nimodipine

1451

Nimorazole

1452

Nintedanib

1453

Niraparib

1454

Niridazole

1455

Nisoldipine

1456

Nitazoxanide

1457

Nitisinone

1458

Nitrazepam

1459

Nitrendipine

1460

Nitric oxide

1461

Nitrofurantoin

1462

Nitrofurazone

1463

Nitrous oxide; when supplied for inhalation

1464

Nitroxoline

1465

Nivolumab

1466

Nizatidine; except when specified elsewhere in this schedule

1467

Nomegestrol

1468

Nomifensine

1469

Noopept (and its stereoisomers)

1470

Noradrenaline

1471

Norandrostenolone

1472

Norbolethone

1473

Norclostebol

1474

Nordazepam

1475

Norelgestromin

1476

Norethandrolone

1477

Norethisterone; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

1478

Norfloxacin

1479

Norgestrel

1480

Noribogaine

1481

Normethandrone

1482

Nortriptyline

1483

Noxiptyline

1484

Nusinersen

1485

Nux vomica; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1486

Nystatin; except when specified elsewhere in this schedule

1487

Obeticholic acid

1488

Obinutuzumab

1489

Ocrelizumab

1490

Ocriplasmin

1491

Octamylamine

1492

Octatropine

1493

Octreotide

1494

Octyl nitrite

1495

Oestradiol; except in medicines containing 10 micrograms or less per litre or per kilogram

1496

Oestriol

1497

Oestrogens

1498

Oestrone; except in medicines containing 1 milligram or less per litre or per kilogram

1499

Ofatumumab

1500

Ofloxacin

1501

Olanzapine

1502

Olaparib

1503

Olaratumab

1504

Oleandomycin

1505

Oleandrin

1506

Olmesartan

1507

Olodaterol

1508

Olopatadine

1509

Olsalazine

1510

Omalizumab

1511

Omberacetam

1512

Ombitasvir

1513

Omeprazole; except when specified elsewhere in this schedule

1514

Ondansetron

1515

Opipramol

1516

Opium

1517

Orciprenaline

1518

Orlistat; except in medicines for weight control containing 120 milligrams or less per dose form

1519

Ornidazole

1520

Ornipressin

1521

Orphenadrine

1522

Orthopterin

1523

Oseltamivir; except when specified elsewhere in this schedule

1524

Osimertinib

1525

Otilonium bromide

1526

Ouabain

1527

Ovandrotone

1528

Oxabolone

1529

Oxacillin

1530

Oxaliplatin

1531

Oxandrolone

1532

Oxaprozin

1533

Oxazepam

1534

Oxazolam

1535

Oxcarbazepine

1536

Oxedrine; except in medicines containing 30 milligrams or less per recommended daily dose

1537

Oxetacaine; except for internal use

1538

Oxiconazole; except when specified elsewhere in this schedule

1539

Oxiracetam (and its stereoisomers)

1540

Oxitropium

1541

Oxolamine

1542

Oxolinic acid

1543

Oxpentifylline

1544

Oxprenolol

1545

Oxybuprocaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1546

Oxybutynin

1547

Oxycodone

1548

Oxymesterone

1549

Oxymetholone

1550

Oxyphenbutazone

1551

Oxyphencyclimine

1552

Oxyphenisatin; at all strengths

1553

Oxyphenonium

1554

Oxytetracycline

1555

Oxytocin; except in medicines containing 1 microgram or less per litre or per kilogram

1556

Ozanimod

1557

Paclitaxel

1558

Palbociclib

1559

Palifermin

1560

Paliperidone

1561

Palivizumab

1562

Palonosetron

1563

Pamaquin

1564

Pamidronic acid

1565

Pancreatic enzymes; except in medicines containing 20 000 BP units or less of lipase activity

1566

Pancuronium

1567

Panitumumab

1568

Panobinostat

1569

Pantoprazole; except when specified elsewhere in this schedule

1570

Papaveretum

1571

Papaverine; for injection

1572

Paracetamol; except when specified elsewhere in this schedule

1573

Paraldehyde

1574

Paramethadione

1575

Paramethasone

1576

Parecoxib

1577

Paricalcitol

1578

Paritabprevir

1579

Paromomycin

1580

Paroxetine

1581

Pasireotide

1582

Patent blue V; for injection when used in diagnostic procedures

1583

Patiromer sorbitex calcium

1584

Pazopanib

1585

Pecazine

1586

Pefloxacin

1587

Pegaptanib

1588

Pegaspargase

1589

Pegfilgrastim

1590

Peginterferon

1591

Peginterferon beta-1a

1592

Pegvisomant

1593

Pembrolizumab

1594

Pemetrexed

1595

Pemoline

1596

Pempidine

1597

Penbutolol

1598

Penciclovir; except when specified elsewhere in this schedule

1599

Penicillamine

1600

Pentaerythrityl tetranitrate

1601

Pentagastrin

1602

Pentamethonium

1603

Pentamidine

1604

Pentazocine

1605

Penthienate

1606

Pentolinium

1607

Pentosan polysulfate sodium

1608

Pentostatin

1609

Pentoxifylline

1610

Peramivir

1611

Perampanel

1612

Pergolide

1613

Perhexiline

1614

Pericyazine

1615

Perindopril

1616

Permethrin; except in medicines containing 5% or less

1617

Perphenazine

1618

Pertussis antigen

1619

Pertussis (whooping cough) vaccine

1620

Pertuzumab

1621

Pethidine

1622

Phenacemide

1623

Phenacetin; except when present as an excipient

1624

Phenaglycodol

1625

Phenazone; except for external use

1626

Phenazopyridine

1627

Phenelzine

1628

Pheneticillin

1629

Phenformin

1630

Phenglutarimide

1631

Phenibut

1632

Phenindione

1633

Pheniramine; except when specified elsewhere in this schedule

1634

Phenisatin

1635

Phenobarbital

1636

Phenol; for injection

1637

Phenolphthalein

1638

Phenoperidine

1639

Phenoxybenzamine

1640

Phenoxymethylpenicillin

1641

Phensuximide

1642

Phentermine

1643

Phenthimentonium

1644

Phentolamine

1645

Phenylbutazone

1646

Phenylephrine; except when specified elsewhere in this schedule

1647

Phenylpiracetam

1648

Phenylpropanolamine

1649

Phenyltoloxamine

1650

Phenytoin

1651

Phleum pratense extract

1652

Pholcodine; except when specified elsewhere in this schedule

1653

Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this schedule

1654

Phthalylsulfathiazole

1655

Physostigmine

1656

Pibrentasvir

1657

Picibanil

1658

Picric acid

1659

Picrotoxin

1660

Pilocarpine; except in medicines containing 0.025% or less

1661

Pimecrolimus

1662

Pimozide

1663

Pinacidil

1664

Pinazepam

1665

Pindolol

1666

Pioglitazone

1667

Pipecuronium

1668

Pipemidic acid

1669

Pipenzolate

1670

Piperacetam

1671

Piperacillin

1672

Piperidine

1673

Piperidolate

1674

Pipobroman

1675

Pipothiazine

1676

Pipradrol

1677

Piracetam

1678

Pirbuterol

1679

Pirenoxine

1680

Pirenzepine

1681

Piretanide

1682

Pirfenidone

1683

Piroxicam; except for external use

1684

Pirprofen

1685

Pitavastatin

1686

Pituitary hormones

1687

Pivampicillin

1688

Pizotifen

1689

Plerixafor

1690

Plicamycin

1691

Plitidepsin

1692

Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1693

Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1694

Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1695

Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1696

Polatuzumab vedotin

1697

Polidexide

1698

Poliomyelitis vaccine

1699

Polyacrylamide; in injections or implants for tissue augmentation or cosmetic use

1700

Polyestradiol

1701

Polylactic acid; in injections or implants for tissue augmentation or cosmetic use

1702

Polymyxin

1703

Polysulfated glycosaminoglycans; for injection except in intraocular viscoelastic products

1704

Polythiazide

1705

Pomalidomide

1706

Ponatinib

1707

Poractant alfa

1708

Posaconazole

1709

Potassium bromide

1710

Potassium perchlorate

1711

Practolol

1712

Pradofloxacin

1713

Pralatrexate

1714

Pralidoxime

1715

Pralmorelin

1716

Pramipexole

1717

Pramiracetam

1718

Pramocaine

1719

Prampine

1720

Prasterone

1721

Prasugrel

1722

Pravastatin

1723

Prazepam

1724

Praziquantel

1725

Prazosin

1726

Prednisolone

1727

Prednisone

1728

Pregabalin

1729

Pregnenolone

1730

Prenalterol

1731

Prenylamine

1732

Prilocaine; for injection except when used as a local anaesthetic in practice by a dental therapist or an oral therapist registered with the Dental Council; except when specified elsewhere in this schedule

1733

Primaquine

1734

Primidone

1735

Probenecid

1736

Probucol

1737

Procainamide

1738

Procaine

1739

Procaine penicillin

1740

Procarbazine

1741

Prochlorperazine; except when specified elsewhere in this schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception

1742

Procyclidine; except for dermal use in medicines containing 5% or less

1743

Progesterone; except in medicines containing 1 milligram or less per litre or per kilogram

1744

Progestogens

1745

Proglumide

1746

Proguanil

1747

Prolintane

1748

Promazine

1749

Promethazine; except when specified elsewhere in this schedule

1750

Promoxolane

1751

Propafenone

1752

Propamidine; except for ophthalmic use

1753

Propanidid

1754

Propantheline

1755

Propetandrol

1756

Propionibacterium acnes

1757

Propofol

1758

Propranolol; except in medicines containing 1 milligram or less per litre or per kilogram

1759

Propylthiouracil

1760

Propyphenazone

1761

Proquazone

1762

Proscillaridin

1763

Prostaglandins

1764

Protamine

1765

Prothionamide

1766

Prothipendyl

1767

Protirelin

1768

Protoveratrines

1760

Protriptyline

1770

Proxymetacaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1771

Prucalopride

1772

Pseudoephedrine

1773

Pulmonaria spp; at all strengths

1774

Pyrazinamide

1775

Pyridinolcarbamate

1776

Pyridostigmine

1777

Pyridoxal; except in medicines containing 200 milligrams or less per recommended daily dose

1778

Pyridoxamine; except in medicines containing 200 milligrams or less per recommended daily dose

1779

Pyridoxine; except in medicines containing 200 milligrams or less per recommended daily dose

1780

Pyrimethamine

1781

Pyrvinium

1782

Quazepam

1783

Quetiapine

1784

Quinagolide

1785

Quinapril

1786

Quinbolone

1787

Quinethazone

1788

Quinidine

1789

Quinine; except in medicines containing 50 milligrams or less per recommended daily dose

1790

Quinisocaine

1791

Quinupristin

1792

Rabeprazole

1793

Rabies vaccine

1794

Racetams; except when specified elsewhere in this schedule

1795

Raloxifene

1796

Raltegravir

1797

Raltitrexed

1798

Ramipril

1799

Ramucirumab

1800

Ranibizumab

1801

Ranitidine; except when specified elsewhere in this schedule

1802

Ranolazine

1803

Rapacuronium

1804

Rasagiline

1805

Rasburicase

1806

Rauwolfia serpentina

1807

Rauwolfia vomitoria

1808

Razoxane

1809

Reboxetine

1810

Recombinant human epidermal growth factor

1811

Recombinant varicella zoster virus glycoprotein E antigen

1812

Regorafenib

1813

Remdesivir

1814

Remestemcel-L

1815

Remifentanil

1816

Remoxipride

1817

Repaglinide

1818

Reserpine

1819

Reslizumab

1820

Retapamulin

1821

Reteplase

1822

Retigabine

1823

Ribavirin

1824

Ribociclib

1825

Ridaforolimus

1826

Rifabutin

1827

Rifampicin

1828

Rifamycin

1829

Rifapentine

1830

Rifaximin

1831

Rilmazafone

1832

Rilpivirine

1833

Riluzole

1834

Rimexolone

1835

Rimiterol

1836

Rimonabant

1837

Riociguat

1838

Ripretinib

1839

Risankizumab

1840

Risedronic acid

1841

Risperidone

1842

Ritodrine

1843

Ritonavir

1844

Rituximab

1845

Rivaroxaban

1846

Rivastigmine

1847

Rizatriptan; except when specified elsewhere in this schedule

1848

Rocuronium

1849

Rofecoxib

1850

Roflumilast

1851

Rolipram (and its stereoisomers)

1852

Rolitetracycline

1853

Rolziracetam

1854

Romidepsin

1855

Romiplostim

1856

Romosozumab

1857

Ropinirole

1858

Ropivacaine

1859

Rosiglitazone

1860

Rosoxacin

1861

Rosuvastatin

1862

Rotavirus vaccine

1863

Rotigotine

1864

Roxibolone

1865

Roxithromycin

1866

Rubella vaccine; except when administered, in combination with measles and mumps vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)

1867

Ruboxistaurin

1868

Rufinamide

1869

Rupatadine

1870

Ruxolitnib

1871

Sabadilla; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1872

Sacubitril

1873

Safinamide

1874

Safrole; for internal use except in medicines containing 0.1% or less

1875

Salbutamol

1876

Salcatonin

1877

Salmeterol

1878

Sapropterin

1879

Saquinavir

1880

Sargramostim

1881

Sarilumab

1882

Saxagliptin

1883

Schoenocaulon officinale; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1884

Scopolia carniolica

1885

Sebelipase alfa

1886

Secbutabarbital

1887

Secobarbital

1888

Secukinumab

1889

Selective androgen receptor modulators

1890

Seletracetam (and its stereoisomers)

1891

Selegiline

1892

Selenium; except when specified elsewhere in this schedule; except for oral use in medicines containing 150 micrograms or less per recommended daily dose

1893

Selexipag

1894

Semaglutide

1895

Serelaxin

1896

Sermorelin

1897

Sertindole

1898

Sertraline

1899

Serum, dried human

1900

Sevelamer

1901

Sevoflurane

1902

Sex hormones and all substances having sex hormone activity

1903

Sialoepoetin

1904

Sibutramine

1905

Silandrone

1906

Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand Incorporated

1907

Silicones; for injection

1908

Silodosin

1909

Siltuximab

1910

Silver sulfadiazine; except for external use in packs containing 50 grams or less

1911

Simeprevir

1912

Simvastatin

1913

Siponimod

1914

Sirolimus

1915

Sisomicin

1916

Sitagliptin

1917

Sitaxentan

1918

Sodium bromide

1919

Sodium cellulose phosphate; for internal use

1920

Sodium cromoglycate; except for nasal and ophthalmic use

1921

Sodium morrhuate; for injection

1922

Sodium nitroprusside

1923

Sodium phenylbutyrate

1924

Sodium phosphate; in oral laxative preparations

1925

Sodium polystyrene sulphonate

1926

Sodium tetradecyl sulphate; for injection

1927

Sodium zirconium cyclosilicate

1928

Sofosbuvir

1929

Solasadine

1930

Solifenacin

1931

Somatostatin

1932

Somatropin

1933

Sonidegib

1934

Sontoquine

1935

Sorafenib

1936

Sotalol

1937

Sparfloxacin

1938

Sparteine

1939

Spectinomycin

1940

Spiramycin

1941

Spirapril

1942

Spironolactone

1943

Squill

1944

Stanolone

1945

Stanozolol

1946

Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1947

Stavudine

1948

Stenabolic (SR9009) and other synthetic REV-ERB agonists

1949

Stenbolone

1950

Steroid hormones

1951

Stilboestrol

1952

Stiripentol

1953

Stramonium; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

1954

Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1955

Streptodornase

1956

Streptokinase

1957

Streptomycin

1958

Streptozocin

1959

Strontium ranelate

1960

Strophanthins

1961

Strophanthus spp

1962

Strychnos spp; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1963

Styramate

1964

Succimer

1965

Sufentanil

1966

Sugammadex

1967

Sulbactam

1968

Sulconazole; except for dermal use

1969

Sulfacetamide; except for ophthalmic use in medicines containing 10% or less

1970

Sulfadiazine; except silver sulfadiazine for external use in pack sizes of 50 grams or less

1971

Sulfadimethoxine

1972

Sulfadimidine

1973

Sulfadoxine

1974

Sulfafurazole

1975

Sulfaguanidine

1976

Sulfamerazine

1977

Sulfamethizole

1978

Sulfamethoxazole

1979

Sulfamethoxydiazine

1980

Sulfamethoxypyridazine

1981

Sulfametrole

1982

Sulfamonomethoxine

1983

Sulfamoxole

1984

Sulfaphenazole

1985

Sulfapyridine

1986

Sulfasalazine

1987

Sulfathiazole

1988

Sulfatroxazole

1989

Sulfinpyrazone

1990

Sulfomyxin

1991

Sulfonmethane

1992

Sulindac

1993

Sultamicillin

1994

Sulthiame

1995

Sumatriptan; except when specified elsewhere in this schedule

1996

Sunifiram

1997

Sunitinib

1998

Suprofen

1999

Suvorexant

2000

Sutilains

2001

Suxamethonium

2002

Suxethonium

2003

T cell receptor antibody

2004

Tacrine

2005

Tacrolimus

2006

Tadalafil and its structural analogues

2007

Tafamidis

2008

Tafenoquine succinate

2009

Tafluprost

2010

Talazoparib

2011

Taliglucerase alfa

2012

Talimogene laherparepvec

2013

Tamoxifen

2014

Tamsulosin

2015

Tanacetum vulgare; except in medicines containing 0.8% or less of oil of tansy

2016

Tapentadol

2017

Tasonermin

2018

Tazarotene

2019

Tazobactam

2020

Teduglutide

2021

Tegafur

2022

Tegaserod

2023

Teicoplanin

2024

Telaprevir

2025

Telbivudine

2026

Telithromycin

2027

Telmisartan

2028

Telotristat ethyl

2029

Temazepam

2030

Temozolomide

2031

Temsirolimus

2032

Tenecteplase

2033

Teniposide

2034

Tenofovir

2035

Tenoxicam

2036

Terazosin

2037

Terbinafine; except when specified elsewhere in this schedule

2038

Terbutaline

2039

Terfenadine

2040

Teriflunomide

2041

Teriparatide

2042

Terlipressin

2043

Terodiline

2044

Teropterin

2045

Tesamorelin

2046

Testolactone

2047

Testosterone; except in medicines containing 1 milligram or less per litre or per kilogram

2048

Tetanus antitoxin

2049

Tetanus toxoid

2050

Tetanus vaccine

2051

Tetrabenazine

2052

Tetracosactrin

2053

Tetracycline

2054

Tetraethylammonium

2055

Tetrahydrocannabinol

2056

Tetrazepam

2057

Tetroxoprim

2058

Thalidomide

2059

Thenyldiamine

2060

Theophylline; except when specified elsewhere in this schedule

2061

Thevetia peruviana

2062

Thevetin

2063

Thiambutosine

2064

Thiazosulfone

2065

Thiethylperazine

2066

Thioacetazone

2067

Thiocarlide

2068

Thioguanine

2069

Thiomesterone

2070

Thiopentone

2071

Thiopropazate

2072

Thioproperazine

2073

Thioridazine

2074

Thiotepa

2075

Thiothixene

2076

Thiouracil

2077

Thiourea; except in medicines containing 0.1% or less

2078

Thymosin beta-4

2079

Thymoxamine

2080

Thyroid

2081

Thyrotrophin

2082

Thyrotrophin-releasing factor

2083

Thyroxine; except in medicines containing 10 micrograms or less per litre or per kilogram

2084

Tiagabine

2085

Tianeptine

2086

Tiaprofenic acid

2087

Tiaramide

2088

Tibolone

2089

Ticagrelor

2090

Ticarcillin

2091

Ticlopidine

2092

Tiemonium

2093

Tienilic acid

2094

Tigecycline

2095

Tigloidine

2096

Tiletamine

2097

Tilidine

2098

Tilmanocept

2099

Tiludronic acid

2100

Timbetasin

2101

Timolol

2102

Tinidazole

2103

Tinzaparin

2104

Tioconazole; except when specified elsewhere in this schedule

2105

Tiotropium

2106

Tipepidine

2107

Tipiracil

2108

Tiprinavir

2109

Tirilazad

2110

Tirofiban

2111

Tivozanib

2112

Tizanidine

2113

Tobramycin

2114

Tocainide

2115

Tocilizumab

2116

Tofacitinib

2117

Tolazamide

2118

Tolazoline

2119

Tolbutamide

2120

Tolcapone

2121

Tolfenamic acid

2122

Tolmetin

2123

Tolonium

2124

Tolpropamine

2125

Tolrestat

2126

Tolterodine

2127

Tolvaptan

2128

Topiramate

2129

Topotecan

2130

Torasemide

2131

Toremifene

2132

Toxoids; for injection

2133

Tramadol

2134

Trametinib dimethyl sulfoxide

2135

Trandolapril

2136

Tranexamic acid

2137

Tranylcypromine

2138

Trastuzumab

2139

Trastuzumab emtansine

2140

Travoprost

2141

Trazodone

2142

Trenbolone

2143

Treosulphan

2144

Treprostinil

2145

Trestolone

2146

Tretamine

2147

Tretinoin

2148

Triacetyloleandomycin

2149

Triamcinolone; except when specified elsewhere in this schedule

2150

Triamterene

2151

Triaziquone

2152

Triazolam

2153

Trichlormethiazide

2154

Trichloroacetic acid; except for external use in medicines containing 12.5% or less for the treatment of warts other than anogenital warts

2155

Trichloroethylene

2156

Trichodesma africana; at all strengths

2157

Triclofos

2158

Tricyclamol

2159

Tridihexethyl

2160

Trientine

2161

Trifluoperazine

2162

Trifluperidol

2163

Triflupromazine

2164

Trifluridine

2165

Trimeprazine; except when specified elsewhere in this schedule

2166

Trimetaphan

2167

Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections

2168

Trimipramine

2169

Trimustine

2170

Trinitrophenol

2171

Trioxysalen

2172

Triparanol; at all strengths

2173

Triple antigen vaccine

2174

Triprolidine; except when specified elsewhere in this schedule

2175

Triptorelin

2176

Troglitazone

2177

Trometamol; for injection in medicines containing more than 3%

2178

Tropicamide; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

2179

Tropisetron

2180

Trovafloxacin

2181

Troxidone

2182

Tryptophan; except in medicines containing 100 milligrams or less per recommended daily dose; except in parenteral nutrition replacement preparations

2183

Tuberculin

2184

Tuberculosis vaccine

2185

Tubocurarine

2186

Tucatinib

2187

Tulobuterol

2188

Typhoid vaccine

2189

Ulipristal

2190

Umeclidinium bromide

2191

Unifiram

2192

Unoprostone

2193

Upadacitinib

2194

Uracil

2195

Urapidil

2196

Urethane

2197

Urofollitropin

2198

Urokinase

2199

Ursodeoxycholic acid

2200

Ustekinumab

2201

Vaccines; except when specified elsewhere in this schedule

2202

Vaccinia virus vaccine

2203

Valaciclovir

2204

Valdecoxib

2205

Valganciclovir

2206

Valnoctamide

2207

Valproic acid

2208

Valsartan

2209

Vancomycin

2210

Vandetanib

2211

Vardenafil and its structural analogues

2212

Varenicline

2213

Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)

2214

Vasopressin

2215

Vecuronium

2216

Vedolizumab

2217

Velaglucerase alfa

2218

Velpatasvir

2219

Vemurafenib

2220

Venetoclax

2221

Venlafaxine

2222

Verapamil

2223

Veratrum spp

2224

Vernakalant

2225

Verteporfin

2226

Veruprevir

2227

Vidarabine

2228

Vigabatrin

2229

Vilanterol

2230

Vildagliptin

2231

Viloxazine

2232

Vinblastine

2233

Vincamine

2234

Vincristine

2235

Vindesine

2236

Vinflunine

2237

Vinorelbine

2238

Vinyl ether

2239

Virginiamycin

2240

Vismodegib

2241

Visnadine

2242

Vitamin A; except for internal use in medicines containing 3 milligrams or less of retinol equivalents per recommended daily dose; except in parenteral nutrition replacement preparations; except for external use in medicines containing 1% or less

2243

Vitamin D; except for external use; except for internal use in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

2244

Voglibose

2245

Vorapaxar

2246

Voretigene neparvovec

2247

Voriconazole

2248

Vorinostat

2249

Vortioxetine

2250

Voxilaprevir

2251

Warfarin

2252

Xamoterol

2253

Xanthinol nicotinate

2254

Ximelagatran

2255

Xipamide

2256

Yellow fever vaccine

2257

Yohimbine

2258

Zafirlukast

2259

Zalcitabine

2260

Zaleplon

2261

Zanamivir

2262

Zidovudine

2263

Zimeldine

2264

Zinc; except for internal use in medicines containing 25 milligrams or less per recommended daily dose; except for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs that have received the consent of the Minister or the Director-General to their distribution as general sale medicines, when sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; except for external use when in medicines containing 5% or less; except in parenteral nutrition replacement preparations

2265

Ziprasidone

2266

Zoledronic acid

2267

Zolmitriptan; except when specified elsewhere in this schedule

2268

Zolpidem

2269

Zonisamide

2270

Zopiclone

2271

Zoster immunoglobulin, human

2272

Zoxazolamine

2273

Zuclopenthixol

Part 2 Restricted medicines

1

Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less

2

Alclometasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

3

Aminophylline; for oral use in liquid form in medicines containing 2% or less

4

Amorolfine; for external use in medicines containing more than 0.25%

5

Aspirin; in slow-release forms; in enteric coated forms containing more than 300 milligrams per dose form

6

Azatadine; for oral use in adults and children over 2 years of age

7

Azelastine; in medicines for ophthalmic use containing 0.05% or less

8

Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

9

Buclizine; for oral use

10

Butoconazole; for vaginal use

11

Chloramphenicol; for ophthalmic use; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Chlorbutol; except when specified elsewhere in this schedule

13

Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

14

Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails containing more than 8%

15

Cimetidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

16

Clemastine; for oral use

17

Clobetasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

18

Clotrimazole; for vaginal use

19

Cyclizine; for oral use other than in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 6 dosage units; for oral use in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

20

Cyproheptadine; for oral use

21

Dexchlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

22

Dextromethorphan; in liquid form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of symptoms of cough and cold in adults and children aged six years and over

23

Di-iodohydroxy quinoline; for vaginal use

24

Diclofenac; in solid dose form in medicines containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs containing not more than 30 tablets or capsules

25

Dimenhydrinate; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

26

Dimethindene; for oral use

27

Diphenhydramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

28

Dithranol

29

Doxylamine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

30

Econazole; for vaginal use

31

Erythrityl tetranitrate

32

Famciclovir; in divided solid dosage forms for oral use containing 500 milligrams or less for the treatment of recurrent herpes labialis when sold in the manufacturer’s original pack containing up to 3 dosage units

33

Flavoxate

34

Fluconazole; for oral use in medicines that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack containing 150 milligrams or less as a single dose for the treatment of vaginal candidiasis

35

Fluorides; for external use in liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as restricted medicines; for external use in non-liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram, except in medicines containing 1.5 grams or less and more than 1 gram per litre or per kilogram; except when supplied to a dental professional registered with the Dental Council

36

Glucagon; except in medicines containing 100 micrograms or less per litre or per kilogram

37

Glyceryl trinitrate; for oral or sublingual use; for rectal use

38

Guaifenesin; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing more than 10 days’ supply but not more than 30 days’ supply; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply; except for oral use in medicines containing 2% or less or 200 milligrams or less per dose form

39

Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

40

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except 5% or less by weight of aciclovir and in a quantity of 2 grams or less or 2 millilitres or less per container in adults and children 12 years of age and older; in rectal medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or up to 12 suppositories per pack

41

Hyoscine butylbromide; for oral use in medicines containing not more than 20 milligrams per dose form and in packs containing not more than 10 tablets or capsules for the relief of muscle spasm of the gastrointestinal tract

42

Ibuprofen; for oral use in tablets or capsules containing up to 400 milligrams per dose form and in packs containing not more than 50 dose units and that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack labelled for use by adults or children over 12 years of age

43

Inositol nicotinate

44

Isoconazole; for vaginal use

45

Ketoprofen; in solid dose form containing 25 milligrams or less per dose form in packs of not more than 30 capsules or tablets

46

Lansoprazole; in divided solid dosage forms for oral use containing 15 milligrams or less with a maximum daily dose of 15 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over for the relief of heartburn when sold in the manufacturer’s original pack containing not more than 14 dosage units

47

Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams

48

Macrogols; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

49

Malathion; except for external use in medicines containing 2% or less

50

Mannityl hexanitrate

51

Meclozine; in a pack size of up to 10 dosage units for the treatment of insomnia

52

Mepyramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

53

Methdilazine; for oral use

54

Metoclopramide; when compounded with paracetamol in packs of not more than 10 tablets or capsules for the treatment of nausea associated with migraine

55

Miconazole; for the treatment of oral candidiasis; for vaginal use

56

Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or less but more than 100 milligrams per dose form; except in medicines containing 100 milligrams or less per dose form

57

Nicotinyl alcohol; except in medicines containing 100 milligrams or less per dose form

58

Nystatin; for the treatment of oral candidiasis; for vaginal use

59

Orlistat; in medicines for weight control containing 120 milligrams or less per dose form

60

Oseltamivir; in solid dosage forms for oral use containing 75 milligrams in a pack size of up to 10 dosage units for the treatment or prophylaxis of influenza in adults and children aged 13 years and older who have been exposed to the influenza virus

61

Oxiconazole; for vaginal use

62

Paracetamol; in modified-release forms containing 665 milligrams or less

63

Pheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

64

Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

65

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

66

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

67

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

68

Prochlorperazine; in packs containing not more than 10 tablets or capsules for the treatment of nausea associated with migraine

69

Promethazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

70

Rizatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms, when in wafers containing 5 milligrams or less per wafer and when sold in a pack containing not more than 2 wafers approved by the Minister or the Director-General for distribution as a restricted medicine

71

Salicylic acid; except in medicines for dermal use containing 40% or less

72

Santonin

73

Sodium phosphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

74

Sodium picosulphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

75

Staphyloccocus aureus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

76

Stramonium; for oral use in liquid form; in solid dose form in medicines containing more than 0.3 milligrams per dose or more than 1.2 milligrams per recommended daily dose

77

Streptococcus beta-haemolyticus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

78

Sulfacetamide; for ophthalmic use in medicines containing 10% or less

79

Sumatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms when in tablets containing 50 milligrams or less per tablet and when sold in a pack containing not more than 2 tablets that has received the consent of the Minister or the Director-General to its sale as a restricted medicine

80

Theophylline; in liquid form for oral use in medicines containing 2% or less

81

Tioconazole; for vaginal use

82

Triamcinolone; for buccal use in medicines containing 0.1% or less of triamcinolone acetonide and in pack sizes of 5 grams or less

83

Trimeprazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

84

Triprolidine; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

85

Zolmitriptan; in a pre-filled nasal spray device containing not more than 5 milligrams of zolmitriptan, for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms and when sold in a pack of not more than 2 devices approved by the Minister or the Director-General for distribution as a restricted medicine

Part 3 Pharmacy-only medicines

1

8-hydroxyquinoline and its non-halogenated derivatives; in medicines containing more than 1% of such substances; except for hydroxyquinoline sulphate for external use

2

Acetic acid and preparations containing more than 80% of acetic acid (CH3COOH); excluding its salts and derivatives

3

Acetylcysteine; for oral use in medicines containing more than 1 gram per recommended daily dose

4

Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 10 grams or less

5

Aconitum spp; for oral use in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids; for dermal use in concentrations of 0.02% or less and in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids

6

Aloes; for internal use; except when obtained solely from the mucilaginous gel of the leaf

7

Aloin

8

Aloxiprin

9

Amethocaine; for external use in medicines containing 10% or less and more than 2%; except in medicines for external use containing 2% or less

10

Amorolfine; in preparations for topical use; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

11

Antazoline; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Atropa belladonna; for external use in medicines containing 0.03% or less of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna

13

Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulphate for the treatment of organophosphorus poisoning either in packs of not more than 20 dose units containing 0.6 milligrams or less per dose unit or in injections in packs of not more than 5 vials containing 0.6 milligrams per millilitre; except when sold as an antidote in a device designed for self-injection from outlets licensed to sell organophosphorus poisons; except in medicines containing 300 micrograms or less per litre or per kilogram

14

Azelaic acid; for dermal use

15

Azelastine; in preparations for nasal use containing 0.15% azelastine hydrochloride or less; in topical eye preparations containing 0.05% or less

16

Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less

17

Benzocaine; in preparations for topical use, other than eye drops, containing 10% or less of total anaesthetic substances except in dermal preparations containing 2% or less of total anaesthetic substances; in divided preparations containing 200 milligrams or less of total anaesthetic substances per dosage unit except in lozenges containing 30 milligrams or less of total anaesthetic substances per dosage unit

18

Benzoyl peroxide; for external use in medicines containing more than 5% and not more than 10%; except for medicines for external use containing 5% or less

19

Benzydamine; for external use except for oromucosal or topical use

20

Bephenium

21

Bifonazole; except when specified elsewhere in this schedule; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

22

Bilastine; in divided solid dosage forms for oral use containing 20 milligrams or less for the treatment of the symptoms of allergic rhinoconjunctivitis (seasonal and perennial)

23

Bisacodyl

24

Bromhexine

25

Brompheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing brompheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

26

Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 64 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril)

27

Carbetapentane; except in medicines containing 0.5% or less

28

Carbocisteine

29

Cetirizine; for oral use except in divided solid dosage forms for oral use containing 10 milligrams or less of cetirizine hydrochloride per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply

30

Chlophedianol

31

Chlorbutol; in medicines containing 5% or less and more than 0.5%; except in medicines containing 0.5% or less

32

Chloroform; in medicines other than for anaesthesia containing more than 0.5%; except in medicines containing 0.5% or less

33

Chlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing chlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

34

Ciclopirox; for external use in medicines containing 2% or less except when for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; in preparations for application to the nails containing 8% or less

35

Cinchocaine; for external use in medicines containing 0.5% or less

36

Cinnamedrine

37

Clotrimazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

38

Cocaine; in medicines for oral use, containing not more than 0.1% of cocaine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, and when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

39

Colocynth

40

Creosote; except in medicines containing 10% or less

41

Cresols; except in medicines containing 3% or less

42

Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

43

Delphinium staphisagria; except in medicines containing 0.2% or less

44

Desloratadine; for oral use

45

Dexchlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing dexchlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

46

Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in liquid form containing 0.25% or less in solid dose form containing 15 milligrams or less per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams

47

Dibrompropamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

48

Diclofenac; in solid dose form in medicines containing 12.5 milligrams or less per dose form in packs containing not more than 30 tablets or capsules and with a recommended daily dose of not more than 75 milligrams

49

Diphenoxylate; in liquid form containing in each millilitre not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate; in solid dose form containing not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate

50

Dimenhydrinate; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults or children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft

51

Diphenhydramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing diphenhydramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft

52

Doxylamine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing doxylamine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

53

Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

54

Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

55

Econazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

56

Esomeprazole; in oral preparations containing 20 milligrams or less per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days’ supply

57

Etafedrine

58

Ether; in medicines containing more than 10%; except in medicines containing 10% or less

59

Etofenamate; for external use

60

Famotidine; for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

61

Felbinac; for external use

62

Fexofenadine; for oral use except for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 120 milligrams when sold in the manufacturer’s original pack containing 20 dosage units or less and not more than 10 days’ supply; for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in tablets containing 180 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 180 milligrams when sold in the manufacturer’s original pack containing 5 dosage units or less and not more than 5 days’ supply

63

Fluorides; for internal use in medicines containing 0.5 milligrams or less per dose unit; except in parenteral nutrition replacement preparations; for external use in liquid form in medicines containing 1 gram or less per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as pharmacy-only medicines except in medicines containing 220 milligrams or less per litre or per kilogram and in packs containing not more than 120 milligrams of total fluoride; except when supplied to any dental professional registered with the Dental Council; except in medicines containing 15 milligrams or less per litre or per kilogram

64

Flurbiprofen; in locally acting oromucosal preparations containing 10 milligrams or less per dosage unit

65

Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation with a maximum recommended daily dose of 200 micrograms (as a single dose)

66

Folic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

67

Folinic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose

68

Formaldehyde; except in medicines containing 5% or less

69

Gelsemium sempervirens; except in medicines containing 1 milligram or less per litre or per kilogram

70

Glutaraldehyde

71

Hexachlorophane; in medicines containing 3% or less but more than 0.75%; except in medicines containing 0.75% or less

72

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 0.5% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or 12 suppositories or fewer per pack

73

Hydrocyanic acid; for oral use in packs containing 5 milligrams or less and more than 0.5 milligrams; except in medicines containing 1 microgram or less per litre or per kilogram; except for oral use in packs containing 0.5 milligrams or less

74

Hydroquinone; for external use in medicines containing 2% or less except in hair preparations containing 1% or less

75

Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

76

Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

77

Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% or less (300 micrograms or less of total solanaceous alkaloids per litre or per kilogram) and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose except in packs containing 30 micrograms or less of total solanaceous alkaloids

78

Ibuprofen; for oral use in liquid form with a recommended daily dose of not more than 1.2 grams for the relief of pain and reduction of fever or inflammation when sold in the manufacturer’s original pack containing not more than 8 grams; for oral use in solid dose form containing not more than 200 milligrams per dose form and with a recommended daily dose of not more than 1.2 grams when sold in the manufacturer’s original pack containing not more than 100 dose units; except in divided solid dosage forms for oral use containing 200 milligrams or less per dose form with a recommended daily dose of not more than 1.2 grams and when sold in the manufacturer’s original pack containing not more than 25 dose units; except for external use

79

Indanazoline

80

Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram

81

Iodine; except for external use in medicines containing 2.5% or less; for internal use in medicines containing less than 300 micrograms per recommended daily dose

82

Ipecacuanha; in medicines containing 0.2% or less of emetine and 40 micrograms or more of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in medicines containing less than 40 micrograms of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years

83

Ipomoea spp; except ipomoea batatas

84

Ipratropium; for nasal use

85

Iron; for oral use either in medicines containing more than 24 milligrams per recommended daily dose or in medicines containing more than 5 milligrams per dose unit and more than 750 milligrams of iron per pack; except in parenteral nutrition replacement preparations; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing not more than 5 milligrams per dose unit; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing more than 5 milligrams per dose unit in packs containing not more than 750 milligrams of iron

86

Isoconazole; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board

87

Isopropamide; for dermal use in preparations containing 2% or less

88

Jalap resin

89

Ketoconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for treatment of the scalp containing 1% or less

90

Ketotifen; for ophthalmic use in medicines containing 0.025% or less except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

91

Leucovorin; in medicines containing more than 500 micrograms per recommended daily dose

92

Levocabastine; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

93

Levocetirizine; for oral use

94

Lignocaine; for urethral use; for external use in medicines containing 10% or less and more than 2%

95

Lindane; for external use in medicines containing 2% or less

96

Lithium; for dermal use in medicines containing 1% or less but more than 0.01%; except for dermal use in medicines containing 0.01% or less

97

Lobelia inflata; except in medicines for smoking or burning

98

Lobeline; except when in medicines for smoking or burning

99

Lodoxamide; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

100

Loperamide; in packs containing not more than 20 tablets or capsules; except in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than 8 dosage forms approved by the Minister or the Director-General for distribution as a general sales medicine for the symptomatic treatment of acute non-specific diarrhoea

101

Loratadine; for oral use; except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply

102

Macrogols; in preparations for oral use as a liquid concentrate for laxative use

103

Mebendazole

104

Meclozine; in a sealed container of not more than 12 tablets or capsules for the prevention or treatment of travel sickness except when sold at a transport terminal or aboard a ship or aircraft

105

Mefenamic acid; in solid dose form in packs containing not more than 30 tablets or capsules for the treatment of dysmenorrhoea

106

Mepyramine; for dermal use; except for external use in medicines containing 2% or less in packs not exceeding 25 grams

107

Mercuric oxide; for ophthalmic use

108

Mercurochrome; in preparations for external use containing 2% or less

109

Mercury; for external use in medicines containing 0.5% or less; except in medicines containing 1 milligram or less per litre or per kilogram

110

Methoxamine; for external use in medicines containing more than 1%; except for external use in medicines containing 1% or less

111

Methoxyphenamine

112

Methylephedrine

113

Miconazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

114

Minoxidil; for dermal use in medicines containing 5% or less

115

Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms (as a single dose) in a pack containing 200 actuations or less

116

Morphine; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

117

Naphazoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

118

Naproxen; in solid dose form containing 250 milligrams or less per dose form in packs of not more than 30 tablets or capsules

119

Niclosamide

120

Nicotine; for inhalation except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist, or psychologist

121

Nizatidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

122

Noscapine

123

Nystatin; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

124

Omeprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

125

Opium; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

126

Oxetacaine; for internal use

127

Oxiconazole; for dermal use except in medicines for tinea pedis only

128

Oxymetazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except for nasal use in medicines containing 0.05% or less when sold in the manufacturer’s original pack with a pack size of 20 millilitres or less

129

Pantoprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

130

Papaverine; except for injection

131

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack; except in tablets or capsules containing 500 milligrams or less and in packs containing not more than 10 grams; except in powder form in sachets containing 1 gram or less and in packs of not more than 10 grams

132

Paraformaldehyde; except in medicines containing 5% or less

133

Penciclovir; for external use for the treatment of herpes labialis; except in medicines for external use containing 1% or less in a pack containing 10 grams or less for the treatment of herpes labialis

134

Phedrazine

135

Phenazone; for external use

136

Pheniramine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing pheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

137

Phenol; except in medicines other than for injection containing 3% or less

138

Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except for nasal or ophthalmic use in medicines containing 1% or less; except for oral use in medicines containing 50 milligrams or less per recommended daily dose and in packs containing 250 milligrams or less of phenylephrine per pack

139

Pholcodine; in medicines for oral use containing not more than 15 milligrams of pholcodine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of pholcodine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

140

Piperazine

141

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

142

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

143

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

144

Potassium; for internal use: in slow-release or enteric coated forms; except for internal use: in medicines containing 100 milligrams or less per recommended dose; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement, or dialysis; except in glucosamine sulphate complexed products containing 600 milligrams or less of potassium chloride per recommended dose; except for external use

145

Potassium chlorate; except in medicines containing 10% or less

146

Prilocaine; for dermal use in medicines containing 10% or less of local anaesthetic substances

147

Procyclidine; for dermal use in medicines containing 5% or less

148

Promethazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing promethazine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft

149

Propamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

150

Pyrantel

151

Pyrethrins; except in medicines containing 10% or less

152

Pyrithione zinc; except in medicines for treatment of the scalp containing 2% or less

153

Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner when sold in the manufacturer’s original pack containing not more than 14 days’ supply; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

154

Salicylamide

155

Selenium; for oral use in medicines containing 300 micrograms or less and more than 150 micrograms per recommended daily dose; for external use except in medicines containing 3.5% or less of selenium sulphide

156

Sennosides

157

Silver; except in oral solutions containing 0.3% or less or other medicines containing 1% or less

158

Silver sulfadiazine; for external use in pack sizes of 50 grams or less

159

Sodium cromoglycate; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

160

Sodium nitrite; except for use as an excipient

161

Sodium picosulphate; in oral laxative preparations

162

Squill; except in medicines containing 1% or less

163

Stramonium; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

164

Sulconazole; for dermal use

165

Sulfadiazine, silver; for external use in pack sizes of 50 grams or less

166

Terbinafine; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

167

Tetrachloroethylene

168

Tetrahydrozoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

169

Thiabendazole

170

Tioconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

171

Tramazoline

172

Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age and when in aqueous nasal sprays delivering up to 55 micrograms per actuation when the maximum recommended daily dose is no greater than 220 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

173

Trimeprazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing trimeprazine or when at least 1 of the other therapeutically active ingredients is a sympathomimetic decongestant

174

Triprolidine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing triprolidine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

175

Tuaminoheptane

176

Tymazoline

177

Xylenols; except in medicines containing 3% or less

178

Xylometazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

179

Zinc chloride; for dermal use in medicines containing more than 5%